-
2024-514952-34-00
5
2023-06-23
Catheter related bloodstream infections due to Staphylococcus aureus
-
2022-501710-62-02
6
2023-06-07
Peripheral T-cell lymphoma (PTCL)
-
2022-501688-42-00
5
2023-05-24
Low Grade Glioma
-
2024-514636-25-00
4
2023-05-04
Stage IIa/IIb < 3 cm seminoma
-
2022-501335-16-00
10
2023-01-16
Interstitial lung disease
-
2023-504484-16-00
9
2022-11-18
Multiple Myeloma (MM)
-
2022-500197-34-01
4
2022-11-03
Megalencephaly-CApillary malformation Polymicrogyria syndrome
-
2024-513490-45-00
5
2022-10-27
Patients hospitalized for allogeneic hematopoietic stem cell transplan
-
2024-513327-16-00
5
2022-09-20
Intensive care
-
2024-513986-38-00
4
2022-06-01
Locally advanced or metastatic papillary cell carcinoma (PRCC)
-
2022-503068-34-00
4
2022-04-06
Metastatic Gastrointestinal Stromal Tumor
-
2023-504166-37-00
4
2022-02-01
Advanced ovarian, tubal or peritoneal cancer.
-
2024-517675-20-00
11
2021-09-28
Labor Induction of women with an unfavorable Cervix after 24 hours of
-
2024-510653-10-00
5
2021-06-04
Advanced or metastatic soft tissue sarcoma (STS) in patients ≥65 years
-
2024-514025-30-00
4
2021-03-25
Ocular conservative treatment for retinoblastoma
-
2024-512671-12-00
10
2021-03-05
Unresectable head and neck squamous cell carcinoma, metastatic head an
-
2024-515019-22-00
5
2021-02-26
Septic shock
-
2024-515276-12-00
5
2020-07-01
Postpartum Hemorrhage
-
2023-507689-26-00
5
2019-10-07
Histologically or cytologically confirmed Locoregional Hepatocellular
-
2024-512629-97-00
4
2019-01-23
Patients with locally advanced or metastatic low grade endometrial str
-
2024-514094-22-00
5
2019-01-18
Intrecerebral Haemorrhage
-
2024-514780-26-00
4
2018-10-23
Patients ≤50 years old with high-risk osteosarcoma (defined as metasta
-
2024-516110-38-00
5
2018-03-06
Hepatoblastoma and Hepatocellular Carcinoma
-
2024-518578-15-00
5
2018-02-05
Is to demonstrate a non inferior efficacy of azithromycin and so the p